Cholecystokinin-mediated neuromodulation of anxiety and schizophrenia: A “dimmer-switch” hypothesis

Review

Abstract: Cholecystokinin (CCK), the most abundant brain neuropeptide, is involved in relevant behavioral func

Palabras claves:

anxiety, Cholecystokinin, dopamine, Gamma-aminobutyric acid, Glutamic acid, Schizophrenia

Autores:

Bourin M., Santiago J. Ballaz

Fuentes:

google

scopus